SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
Published on June 2, 2014
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM SD
Specialized Disclosure Report
ResMed Inc.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 001-15317 | 98-0152841 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
9001 Spectrum Center Blvd.
San Diego, California 92123
(Address of Principal Executive Offices)
David Pendarvis
(858) 836-5000
(Name and telephone number, including area code, of the person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
| x | Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2013 |
Section 1 - Conflict Minerals Disclosure
Item 1.01 and 1.02 Conflict Minerals Disclosure and Report, Exhibit
Conflict Minerals Disclosure
A copy of ResMed Inc.s Conflict Minerals Report for the reporting period January 1, 2013 to December 31, 2013 is provided as Exhibit 1.02 and is available at www.resmed.com> For Investors > Board and Management > Corporate Governance.
Section 2 Exhibits
Item 2.01 Exhibits
Exhibit 1.02 Conflict Minerals Report for the reporting period January 1, 2013 to December 31, 2013.
2
SIGNATURES
We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.
| Date: June 2, 2014 | RESMED INC. | |||||
| (registrant) | ||||||
| By: | /s/ David Pendarvis |
|||||
| Name: | David Pendarvis | |||||
| Its: | Chief administrative officer, global general counsel and secretary | |||||
3
EXHIBIT INDEX
| Exhibits: |
Description of Document |
|
| 1.02 | Conflict Minerals Report for the reporting period January 1, 2013 to December 31, 2013 | |